+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Age-related decreases in striatal dopamine transporter and vesicular monoamine transporter binding sites in alcoholics



Age-related decreases in striatal dopamine transporter and vesicular monoamine transporter binding sites in alcoholics



Alcoholism Clinical & Experimental Research 22(3 ABSTR Suppl. ): 48A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029938784

Download citation: RISBibTeXText


Related references

HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. Journal of Neuroimmune Pharmacology 7(3): 629-639, 2012

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology 40(3): 428-439, 1996

Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain. Experimental Neurology 188(2): 387-390, 2004

No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. Plos one 7(2): E31439, 2012

Rapid and differential losses of in vivo dopamine transporter and vesicular monoamine transporter radioligand binding in MPTP-treated mice. Synapse (New York) 35(4): 250-255, 2000

Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse 35(4): 250-255, 2000

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. Synapse 61(7): 573-576, 2007

Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology 47(2): 368-373, 1995

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos one 7(11): E49483, 2012

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. Journal of Neurochemistry 111(5): 1202-1212, 2009

Methamphetamine decreases mouse vesicular monoamine transporter 2 activity role of hyperthermia and dopamine. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 343 8, 2002

The inhibition of vesicular monoamine transporter 2 partially reduces the toxicity of 6-hydroxydopamine on nigro-striatal dopamine neurons. Society for Neuroscience Abstracts 27(1): 1148, 2001

Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Journal of Neurochemistry 85(4): 898-910, 2003

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. Journal of Neuroscience 16(10): 3507-3510, 1996

Coordinated expression of dopamine transporter and vesicular monoamine transporter in the primate striatum during development. Synapse 67(9): 580-585, 2013